Loading
Latest filing published 10 Nov 2025 for Hansa Biopharma AB, €71k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
One trade, one date: on 10 November 2025, Charles Ballantyne disclosed an open-market purchase of €71k in Hansa Biopharma AB. No broader history exists yet. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration